[Skip to Content]
[Skip to Content Landing]

A 13-Year-Old Boy With Subacute-Onset Spastic Gait

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A 13-year-old boy with an unsteady gait was referred for evaluation. He had been well until 1 month prior, when he developed lower limb weakness after eating a vegetarian diet for 15 days. His medical and family histories were unremarkable. His walking had become unsteady, and he was less talkative. On examination, he scored 24 on a Mini-Mental State Examination, with impairments in temporal and spatial orientation, calculation, and short-term memory. Horizontal nystagmus was observed. His lower limb strength was 4 of 5 proximally and 5− of 5 distally, with increased muscle tone. Patellar reflexes were brisk. Ankle clonus and Babinski signs were present bilaterally. His gait was spastic (Video). Blood test results indicated normocytic anemia (hemoglobin level, 126 g/L; reference, >130 g/L [to convert to grams per deciliter, multiply by 0.1]), borderline folate elevation (2.15 ng/mL; reference, >2 μg/L [to convert nanomoles per liter, multiply by 2.266]), and an increased homocysteine level (8.85 mg/L; reference, <2.03 mg/L [to convert to micromoles per liter, multiply by 7.397]). Results of stool analysis; liver and kidney function tests; myocardial enzyme, electrolyte, ammonia, trace element, and B12 levels; thyroid function, arterial blood gas, antinuclear antibodies, and intrinsic factor antibody tests; and an infection panel test were unremarkable. Magnetic resonance imaging showed mild cerebral atrophy and a hyperintense T2-weighted signal in the cervical spinal cord. Electromyography results were normal. Electroencephalography showed diffuse background slowing with scattered epileptiform discharges. Urine organic acid analysis indicated methylmalonic acidemia. A serum amino acid analysis was nondiagnostic (Figure 1). Cerebrospinal fluid was normal.

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

B. Cobalamin C deficiency

This teenager presented with subacute-onset spastic gait and homocysteine elevation. Homocysteinemia can be acquired or inherited with or without methylmalonic acidemia. His age, normal vitamin and folate levels, and lack of intrinsic factor antibodies suggested an inherited metabolic disorder. Elevation of methylmalonic acid (MMA) narrowed the differential diagnosis.

Methylmalonic acidemia with homocysteinemia is caused by defects in the absorption, transportation, and metabolism of cobalamin.1 Normally, after entering the cell, cobalamin is reduced to cobalamin II through functions of cobalamin F, J, C, and D. Next, cobalamin II is converted to methyl-cobalamin, remethylating homocysteine to methionine. Alternatively, cobalamin II can be converted to adenosyl-cobalamin, a cofactor for methylmalonyl-CoA mutase, which converts L-methylmalonyl-CoA to succinyl-CoA. Blocking this step results in accumulation of L-methylmalonyl-CoA metabolites, which include MMA and methyl citrate acid. Therefore, any defect affecting conversion of cobalamin to cobalamin II will cause simultaneous elevations in homocysteine and MMA, leading to neuronal and endothelial dysfunctions. A cobalamin C (CblC) deficiency (choice B) is most likely. Hereditary spastic paraplegia (choice A) can present with spastic gait, encephalopathy, and seizure but cannot explain the abnormal biochemical results. Cystathionine β-synthase and methionine synthase catalyze conversion of homocysteine to cystathionine and methionine, respectively. Although defects in cystathionine β-synthase (choice C) or cobalamin G or methionine synthase (choice D) can cause homocysteinemia, neither leads to elevated MMA because adenosylcobalamin is unaffected.

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Qiying Sun, MD, PhD, Geriatric Neurology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan 410008, China (sunqiying2015@163.com).

Published Online: June 28, 2021. doi:10.1001/jamaneurol.2021.1953

Conflict of Interest Disclosures: The authors report a grant from the National Natural Sciences Foundation of China (U20A20355). No other disclosures were reported.

Additional Contributions: We thank the patient’s parent for granting permission to publish this.

References
1.
Sloan  JL , Castillo  N , Adams  D , Venditti  CP . Disorders of intracellular cobalamin metabolism. In: Adam  MP , Ardinger  HH , Pagon  RA ,  et al.  GeneReviews. University of Washington;2008. https://www.ncbi.nlm.nih.gov/books/NBK1328/.
2.
Han  B , Cao  Z , Tian  L ,  et al.  Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China.   Brain Dev. 2016;38(5):491-497. doi:10.1016/j.braindev.2015.10.016PubMedGoogle ScholarCrossref
3.
Carrillo-Carrasco  N , Venditti  CP .  Combined methylmalonic acidemia and homocystinuria, cblC type II.   J Inherit Metab Dis. 2012;35(1):103-114. doi:10.1007/s10545-011-9365-xPubMedGoogle ScholarCrossref
4.
Huemer  M , Diodato  D , Schwahn  B ,  et al.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.   J Inherit Metab Dis. 2017;40(1):21-48. doi:10.1007/s10545-016-9991-4PubMedGoogle ScholarCrossref
5.
Fischer  S , Huemer  M , Baumgartner  M ,  et al.  Clinical presentation and outcome in a series of 88 patients with the cblC defect.   J Inherit Metab Dis. 2014;37(5):831-840. doi:10.1007/s10545-014-9687-6PubMedGoogle ScholarCrossref
6.
Roe  CR , Hoppel  CL , Stacey  TE , Chalmers  RA , Tracey  BM , Millington  DS .  Metabolic response to carnitine in methylmalonic aciduria.   Arch Dis Child. 1983;58(11):916-920. doi:10.1136/adc.58.11.916PubMedGoogle ScholarCrossref
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close